{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:06:16Z","timestamp":1794441976438,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009102","name":"Jiangxi Provincial Department of Education","doi-asserted-by":"publisher","award":["GJJ190010"],"award-info":[{"award-number":["GJJ190010"]}],"id":[{"id":"10.13039\/501100009102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","award":["PY201914"],"award-info":[{"award-number":["PY201914"]}],"id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangxi Provincial Natural Science Foundation, China","award":["20202BABL216052"],"award-info":[{"award-number":["20202BABL216052"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81760435"],"award-info":[{"award-number":["81760435"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.lfs.2020.118316","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T10:57:03Z","timestamp":1598007423000},"page":"118316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma"],"prefix":"10.1016","volume":"261","author":[{"given":"Qin","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.118316_bb0005","first-page":"394","article-title":"Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma","volume":"62","author":"Maluccio","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2020.118316_bb0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1200\/JCO.18.00885","article-title":"Influence of HIV infection on the natural history of hepatocellular carcinoma: results from a global multicohort study","volume":"37","author":"Pinato","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.lfs.2020.118316_bb0015","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.lfs.2020.118316_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/gut.51.4.459","article-title":"Hepatocellular carcinoma: is current therapy really altering outcome?","volume":"51","author":"Johnson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.lfs.2020.118316_bb0025","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.surg.2006.06.033","article-title":"Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection","volume":"141","author":"Yang","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.lfs.2020.118316_bb0030","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41418-019-0473-8","article-title":"Deubiquitinating enzyme USP33 restrains docetaxel-induced apoptosis via stabilising the phosphatase DUSP1 in prostate cancer","volume":"27","author":"Guo","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2020.118316_bb0035","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1074\/jbc.M108269200","article-title":"Ubiquitination of a novel deubiquitinating enzyme requires direct binding to von Hippel-Lindau tumor suppressor protein","volume":"277","author":"Li","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2020.118316_bb0040","first-page":"1","article-title":"USP33 deubiquitinates PRKN\/parkin and antagonizes its role in mitophagy","author":"Niu","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.lfs.2020.118316_bb0045","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.cub.2009.07.040","article-title":"Deubiquitinase activities required for hepatocyte growth factor-induced scattering of epithelial cells","volume":"19","author":"Buus","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.lfs.2020.118316_bb0050","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.biocel.2011.05.016","article-title":"Type 2 deiodinase at the crossroads of thyroid hormone action","volume":"43","author":"Arrojo","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118316_bb0055","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1159\/000494238","article-title":"Radiation Enhances the Epithelial- Mesenchymal Transition of A549 Cells via miR3591-5p\/USP33\/PPM1A","volume":"50","author":"Zhong","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.lfs.2020.118316_bb0060","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1002\/ijc.29226","article-title":"USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration","volume":"136","author":"Huang","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.lfs.2020.118316_bb0065","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/s13238-014-0070-z","article-title":"USP33, a new player in lung cancer, mediates Slit-Robo signaling","volume":"5","author":"Wen","year":"2014","journal-title":"Protein Cell"},{"key":"10.1016\/j.lfs.2020.118316_bb0070","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1159\/000488041","article-title":"USP33 is a biomarker of disease recurrence in papillary thyroid carcinoma","volume":"45","author":"Jia","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.lfs.2020.118316_bb0075","doi-asserted-by":"crossref","first-page":"14530","DOI":"10.1073\/pnas.0801262106","article-title":"Deubiquitinating enzyme USP33\/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration","volume":"106","author":"Yuasa-Kawada","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2020.118316_bb0080","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1126\/science.1846706","article-title":"Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product","volume":"251","author":"Bottaro","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.lfs.2020.118316_bb0085","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrm1261","article-title":"Met, metastasis, motility and more","volume":"4","author":"Birchmeier","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118316_bb0090","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2013.09.009","article-title":"Met as a therapeutic target in HCC: facts and hopes","volume":"60","author":"Giordano","year":"2014","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2020.118316_bb0095","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/cas.13156","article-title":"Hepatocyte growth factor\/MET in cancer progression and biomarker discovery","volume":"108","author":"Matsumoto","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.lfs.2020.118316_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1023\/A:1023768811842","article-title":"Christensen J and Salgia R: c-Met: structure, functions and potential for therapeutic inhibition","volume":"22","author":"Ma","year":"2003","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.lfs.2020.118316_bb0105","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.7150\/ijms.44952","article-title":"The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases","volume":"17","author":"Wang","year":"2020","journal-title":"Int J Med Sci ."},{"key":"10.1016\/j.lfs.2020.118316_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2020.129650","article-title":"The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents","volume":"1864","author":"Park","year":"2020","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"10.1016\/j.lfs.2020.118316_bb0115","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10555-007-9107-6","article-title":"The Met tyrosine kinase receptor in development and cancer","volume":"27","author":"Gentile","year":"2008","journal-title":"Cancer Metastasis Rev."},{"issue":"188","key":"10.1016\/j.lfs.2020.118316_bb0120","article-title":"FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression","volume":"38","author":"Hu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118316_bb0125","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1158\/0008-5472.CAN-04-2650","article-title":"Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer","volume":"65","author":"Ma","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2020.118316_bb0130","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2011.03.014","article-title":"Tolfenamic acid inhibits ovarian cancer cell growth and decreases the expression of c-Met and survivin through suppressing specificity protein transcription factors","volume":"122","author":"Basha","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.lfs.2020.118316_bb0135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrm.2017.83","article-title":"Ubiquitylation at the crossroads of development and disease","volume":"19","author":"Rape","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2020.118316_bb0140","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2020.118316_bb0145","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.cell.2009.04.042","article-title":"Defining the human deubiquitinating enzyme interaction landscape","volume":"138","author":"Sowa","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2020.118316_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12606","article-title":"Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT","volume":"52","author":"Xia","year":"2019","journal-title":"Cell Prolif."},{"key":"10.1016\/j.lfs.2020.118316_bb0155","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10555-014-9522-4","article-title":"Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine","volume":"33","author":"Ryu","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.lfs.2020.118316_bb0160","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrc.2018.15","article-title":"Cell motility in cancer invasion and metastasis: insights from simple model organisms","volume":"18","author":"Stuelten","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2020.118316_bb0165","first-page":"3241","article-title":"c-MET and HGF mRNA expression in hepatocellular carcinoma: correlation with clinicopathological features and survival","volume":"33","author":"Ang","year":"2013","journal-title":"Anticancer Res."},{"key":"10.1016\/j.lfs.2020.118316_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.phrs.2011.11.011","article-title":"Targeting c-Met as a promising strategy for the treatment of hepatocellular carcinoma","volume":"65","author":"Gao","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2020.118316_bb0175","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1158\/1078-0432.CCR-12-2791","article-title":"Targeting the HGF\/c-MET pathway in hepatocellular carcinoma","volume":"19","author":"Goyal","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2020.118316_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.07.022","article-title":"Transcriptional regulation by post-transcriptional modification--role of phosphorylation in Sp1 transcriptional activity","volume":"508","author":"Chu","year":"2012","journal-title":"Gene"},{"key":"10.1016\/j.lfs.2020.118316_bb0185","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2015.05.008","article-title":"Sp1 transcription factor: a long-standing target in cancer chemotherapy","volume":"152","author":"Vizcaino","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2020.118316_bb0190","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/febs.13148","article-title":"Sp1 and the \u2018hallmarks of cancer\u2019","volume":"282","author":"Beishline","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.lfs.2020.118316_bb0195","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/1940-6207.CAPR-17-0407","article-title":"Specificity protein transcription factors and cancer: opportunities for drug development","volume":"11","author":"Safe","year":"2018","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.lfs.2020.118316_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21031153","article-title":"Understanding the role of the transcription factor Sp1 in ovarian cancer: from theory to practice","volume":"21","author":"Vellingiri","year":"2020","journal-title":"Int. J. Mol. Sci."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520310687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:38:15Z","timestamp":1758400695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520310687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":40,"alternative-id":["S0024320520310687"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118316","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.118316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"118316"}}